0 Comments
0 Shares
410 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Chronic Thromboembolic Pulmonary Hypertension Market is driven by Rising Prevalence of Deep Vein Thrombosis GloballyChronic thromboembolism is a serious medical condition characterized by persistent blood clots in the pulmonary arteries, leading to pulmonary hypertension and potentially life-threatening complications. The market encompasses various treatment options, including anticoagulation therapy, surgical interventions, and advanced medical devices designed for clot removal and prevention. The condition...0 Comments 0 Shares 819 Views 0 Reviews
-
Iloprost Market Expands with Growing Adoption in Pulmonary Hypertension and Vascular Therapy"Executive Summary Iloprost Market : In this Iloprost Market report, industry trends are put together on macro level which aids in comprehending market place and possible future issues. This market report is an outcome of incessant efforts lead by clued-up forecasters, innovative analysts and bright researchers who indulge in detailed and attentive research on different...0 Comments 0 Shares 347 Views 0 Reviews
-
Pulmonary Arterial Hypertension Market Insights, Competitive Landscape & Forecast (2024–2032) | UnivDatosAccording to the UnivDatos, the surge in the incidence of pulmonary arterial hypertension cases and the rise in demand for personalized medicine will drive the global scenario of Pulmonary Arterial Hypertension. As per their “Pulmonary Arterial Hypertension Market” report, the global market was valued at USD 7.5 billion in 2023, growing at a CAGR of about 5% during the forecast...0 Comments 0 Shares 291 Views 0 Reviews
-
Pulmonary Hypertension Drugs Market is driven by Rising Disease PrevalencePulmonary hypertension drugs encompass a diverse portfolio of therapeutic agents designed to lower pulmonary arterial pressure, improve right ventricular function and enhance patient quality of life. Key classes include endothelin receptor antagonists (ERAs), phosphodiesterase type 5 (PDE-5) inhibitors, prostacyclin analogs and soluble guanylate cyclase (sGC) stimulators. These products offer...0 Comments 0 Shares 348 Views 0 Reviews
-
Pulmonary Hypertension Treatments Accelerate Growth of Iloprost Market"Executive Summary Iloprost Market : CAGR Value Data Bridge Market Research analyses that the Global Iloprost Market which was USD 106.17 million in 2022, would rocket up to USD 212.23 million by 2030, and is expected to undergo a CAGR of 11.50% during the forecast period 2023-2030. As it is important to have valuable and actionable market insights for creating...0 Comments 0 Shares 38 Views 0 Reviews
-
CTEPH Market Expansion Driven by Innovative TherapiesThe Chronic Thromboembolic Pulmonary Hypertension (CTEPH) market encompasses a suite of diagnostic and therapeutic products designed to address the unique challenges of persistent pulmonary arterial obstruction. Key offerings include advanced imaging technologies such as ventilation/perfusion (V/Q) scans and CT pulmonary angiography, together with interventional procedures like pulmonary...0 Comments 0 Shares 436 Views 0 Reviews